MARATTO

article · European Journal of Pharmacology

Cilostazol attenuates cisplatin-induced acute liver injury by targeting the SIRT1/AMPK/PGC-1α signaling pathway, with an impact on miRNA-34a

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Sirtuins and Resveratrol in Medicine
  • Genomics, phytochemicals, and oxidative stress
  • Chemotherapy-induced organ toxicity mitigation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.ejphar.2025.177609

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.